No Data
No Data
Aurora Vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
Tilray Medical Announces Positive Results From Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Toronto Stocks Advance; IA Financial Rises on 3Q Profit, Insurance-Earnings Beat
Cannabis Stocks Fall as Florida Rejects Legalization of Recreational Marijuana
No Data
No Data
Ultratech : trump doesn't drink he only blows Adderall
TheDylz : It’s got nothing to do with that…management is failing epically Irwin needs to get voted out and so does remaining apha management. Too much dilution and overpaid. Keeps diluting to buy failing companies to try and keep earnings afloat plus no brand recognition just a bunch of random brands people who buy it may not even know it’s a tilray product…also not surprised there is a shareholder lawsuit regarding the dilution and wouldn’t be surprised to see another short report…in one of his recent interviews he talks about share buyback lmao while asking shareholders to vote for dilution this seems like a breach of fiduciary duty…also he’s quick to blame previous management for current sentiment which was years ago and talks about volume and compares it to apple and amazon stock lol this is people selling